GCPII-IN-1 TFA is a peptide-like inhibitor scaffold targeting glutamate carboxypeptidase II in biochemical assays. Carboxylate and amide groups mimic key substrate interactions within the active site. Researchers assess binding constants, catalytic suppression, and structural complementarity by enzymology and docking. Applications include enzyme-mechanism elucidation, inhibitor-design research, and neurochemical pathway studies.
CAT No: R2721
CAS No:1269794-89-9
Synonyms/Alias:GCPII-IN-1 TFA;GCPII-IN-1 (TFA);1269794-89-9;(2S)-2-[[(1S)-5-amino-1-carboxypentyl]carbamoylamino]pentanedioic acid;2,2,2-trifluoroacetic acid;EX-A10938;HY-139840A;DA-73673;MS-27735;CS-0255869;E72657;(((S)-5-Amino-1-carboxypentyl)carbamoyl)-L-glutamic acid compound with 2,2,2-trifluoroacetic acid (1:1);
If you have any peptide synthesis requirement in mind, please do not hesitate to contact us at . We will endeavor to provide highly satisfying products and services.
Creative Peptides is a trusted CDMO partner specializing in high-quality peptide synthesis, conjugation, and manufacturing under strict cGMP compliance. With advanced technology platforms and a team of experienced scientists, we deliver tailored peptide solutions to support drug discovery, clinical development, and cosmetic innovation worldwide.
From custom peptide synthesis to complex peptide-drug conjugates, we provide flexible, end-to-end services designed to accelerate timelines and ensure regulatory excellence. Our commitment to quality, reliability, and innovation has made us a preferred partner across the pharmaceutical, biotechnology, and personal care industries.
Read More